Dabur India units face lawsuits in US, Canada alleging products caused cancer - Video
|
Overview
Indian multinational consumer goods company, Dabur India Ltd met with twin controversies in both India and abroad, as it has received a GST Rs 321 crore notice in India, and on the other hand, its subsidiaries has been subjected to series of lawsuits in U.S. and Canada by the consumers over the allegations that hair relaxer products cause had caused ovarian cancer, uterine cancer and other health issues.
In India, Dabur received a notice from the Government regarding the payment of GST short paid / not paid amounting to Rs. 3,20,60,53,069/- along with applicable interest and penalty.
For more details, check out the link given below:
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
